Fusion Antibodies PLC Ordinary Shares (FAB)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

19.00p

Buy

19.50p

arrow-up1.625p (+9.22%)

Prices updated at 12 Dec 2025, 17:28 GMT

Prices minimum 15 mins delay

Prices in GBX

Fusion Antibodies PLC is engaged in the research, development and manufacturing of recombinant proteins and antibodies, particularly in the areas of cancer and infectious diseases.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

11 Dec 2025

25 Nov 2025

24 Nov 2025

21 Nov 2025

13 Nov 2025

03 Nov 2025

27 Oct 2025

16 Oct 2025

08 Oct 2025

Key dates

	Forecast date
Half yearly results	Nov 2026
Annual general meeting	Oct 2026
Annual report	Sep 2026
Final results	Sep 2026

	Previous date
Half yearly results	Nov 2025
Annual general meeting	Oct 2025
Annual report	Sep 2025
Final results	Sep 2025

Company reports

31 Mar 2025

Annual Report

30 Sep 2025

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.